Vaso-occlusive Crisis: Clinical Trials

3 trials for Vaso-occlusive Crisis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow Vaso-occlusive Crisis: new trials by email Literature Review of Vaso-occlusive Crisis trials Research Report on Vaso-occlusive Crisis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
Inclacumab, Placebo - Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease
Phase 3CompletedPfizer2412021-10-042025-12-02
Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia
Omega 3, Vit D, Zinc sulfate - Vaso-occlusive Crisis, Sickle Cell Disease
Phase 2 / Phase 3CompletedBeni-Suef University3502019-11-012021-01-27
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Saline, MST-188 - Vaso-occlusive Crisis, Sickle Cell Disease
Phase 3CompletedMast Therapeutics, Inc.3882013-05-012016-10-28

Narrower conditions

Anemia, Sickle Cell (3)  ·  Vaso-Occlusive Crises (3)  ·  Hematologic Diseases (1)  ·  Sickle Cell Trait (1)

Broader conditions

Anemia (3)  ·  Anemia, Hemolytic (3)  ·  Anemia, Hemolytic, Congenital (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemoglobinopathies (3)  ·  Hematologic Diseases (2)

Interventions

Cardiovascular Agents (1)  ·  Docosahexaenoic Acids (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Hydroxyurea (1)  ·  Morphine (1)  ·  Simvastatin (1)  ·  Sodium Chloride (1)  ·  Zinc Sulfate (1)  ·  inclacumab (1)

Sponsors

Beni-Suef University (1)  ·  Mast Therapeutics, Inc. (1)  ·  Pfizer (1)

Countries

Brazil (2)  ·  Egypt (2)  ·  Lebanon (2)  ·  Oman (2)  ·  Saudi Arabia (2)  ·  Turkey (Türkiye) (2)  ·  United States (2)  ·  Belgium (1)  ·  Colombia (1)  ·  Dominican Republic (1)  ·  France (1)  ·  Jamaica (1)  ·  Jordan (1)  ·  Kenya (1)  ·  Nigeria (1)

Top investigators

Ahmed F Mahmoud Hussein, MS.c (1)  ·  Edwin L. Parsley, D.O. (1)

Results publications

PMID 33877274